Uploaded November 2026 | Updated November 2026, 2 days ago
GLP-1 medications revolutionized the way we treat chronic weight management and diabetes by helping to quiet “food noise”. Researchers are now looking into whether these medications can also be used to dampen “drug noise” and help treat people with substance use disorders.
Alanna Smith is a health reporter for The Globe and she’s been looking into what’s going on with the research around GLP-1s being used to tread opioid addiction. She’s on the show to talk about the excitement and the reluctance on this potential treatment.
Subscribe to The Globe and Mail's Morning Update to get stories directly in your inbox: theglobeandmail.com/newsletters/subscribe-morning-update
GLP-1 medications revolutionized the way we treat chronic weight management and diabetes by helping to quiet “food noise”. Researchers are now looking into whether these medications can also be used to dampen “drug noise” and help treat people with substance use disorders.
Alanna Smith is a health reporter for The Globe and she’s been looking into what’s going on with the research around GLP-1s being used to tread opioid addiction. She’s on the show to talk about the excitement and the reluctance on this potential treatment.
Subscribe to The Globe and Mail's Morning Update to get stories directly in your inbox: theglobeandmail.com/newsletters/subscribe-morning-update










